| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000035395 |
| Receipt No. | R000040323 |
| Scientific Title | Investigation of germline mutation analysis via novel gene panel in Japan |
| Date of disclosure of the study information | 2018/12/28 |
| Last modified on | 2020/12/28 (Ver. 4) |
| Basic information | ||
| Public title | Investigation of germline mutation analysis via novel gene panel in Japan | |
| Acronym | INSIGNIA study | |
| Scientific Title | Investigation of germline mutation analysis via novel gene panel in Japan | |
| Scientific Title:Acronym | INSIGNIA study | |
| Region |
|
|
| Condition | |||
| Condition | Hereditary cancer, Familial hypercholesterolemia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | The purpose is to detect genetic varitants of those who are suspicious of hereditary cancer or familial hypercholesterolemia(FH) using the hereditary cancer gene panel and the FH gene panel. The target population is Japanese and data collected through these panels will be analyzed for genetic varitants, allele frequencies, and clinical information. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Ratio of those with genetic variants, genetic variants, association of genetic variants and family/personal medical history |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Individuals who are suspicisou of hereditary cancer
-Individuals who are suspicisou of familial hypercholestrolemia |
|||
| Key exclusion criteria | -those who cannot consent | |||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Medical and Dental University | ||||||
| Division name | Department of Medical Genetics | ||||||
| Zip code | 113-8519 | ||||||
| Address | 1-5-45 Yushima, Bunkyo, Tokyo, Japan | ||||||
| TEL | 03-5803-4085 | ||||||
| idenbec@tmd.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Medical and Dental University | ||||||
| Division name | Department of Medical Genetics | ||||||
| Zip code | 1138519 | ||||||
| Address | Bunkyo-ku | ||||||
| TEL | +81358034617 | ||||||
| Homepage URL | |||||||
| masa.vasc@tmd.ac.jp | |||||||
| Sponsor | |
| Institute | Tokyo Medical and Dental University
Department of Medical Genetics |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Patient pay |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Medical and Dental University |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo |
| Tel | 03-5803-5096 |
| rec.adm@tmd.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040323 |